This track addresses the development, validation, and application of biomarkers that quantify biological aging and predict health outcomes. Topics include composite biomarker panels, epigenetic clocks, proteomic and metabolomic signatures, imaging markers, and functional measures such as frailty indices. Biomarkers of Aging and Biological Age Presentations will focus on criteria for robust biomarkers, including reliability, sensitivity to change, and association with morbidity, mortality, and intervention response. The session will also explore regulatory and methodological issues in using biomarkers as surrogate endpoints in clinical trials. Contributions that compare different biomarker platforms, examine multi-marker approaches, or apply biomarkers in diverse populations and real-world settings are strongly encouraged.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom